Literature DB >> 32574858

A scaffold laden with mesenchymal stem cell-derived exosomes for promoting endometrium regeneration and fertility restoration through macrophage immunomodulation.

Liaobing Xin1, Xiaona Lin2, Feng Zhou2, Chao Li2, Xiufen Wang2, Huaying Yu2, Yibin Pan2, Haiyi Fei2, Lie Ma3, Songying Zhang4.   

Abstract

Endometrial traumas may cause intrauterine adhesions (IUAs), leading to infertility. Conventional methods in clinic have not solved the problem of endometrial regeneration in severe cases. Umbilical cord-derived mesenchymal stem cell (UC-MSC)-based therapies have shown some promising achievements in the treatment of IUAs. However, the limitations of potential tumorigenicity, low infusion and low retention are still controversial and restricted the clinical application of MSCs. In contrast, UC-MSC-derived exosomes exhibit a similar function to their source cells and are expected to overcome these limitations. Therefore, a novel and viable cell-free therapeutic strategy by UC-MSC-derived exosomes was proposed in this study. Here, we designed a construct of exosomes and collagen scaffold (CS/Exos) for endometrial regeneration in a rat endometrium-damage model, and investigated the regeneration mechanism through macrophage immunomodulation. The CS/Exos transplantation potently induced (i) endometrium regeneration, (ii) collagen remodeling, (iii) increased the expression of the estrogen receptor α/progesterone receptor, and (iv) restored fertility. Mechanistically, CS/Exos facilitated CD163+ M2 macrophage polarization, reduced inflammation, and increased anti-inflammatory responses in vivo and in vitro. By RNA-seq, miRNAs enriched in exosomes were the main mediator for exosomes-induced macrophage polarization. Overall, we demonstrated that CS/Exos treatment facilitated endometrium regeneration and fertility restoration by immunomodulatory functions of miRNAs. Our research highlights the therapeutic prospects of CS/Exos for the management of IUAs. STATEMENT OF SIGNIFICANCE: Severe endometrial traumas always result in intrauterine adhesions (IUAs) and infertility. The limited outcomes by conventional methods in the clinic make it very important to develop new strategies for endometrium regeneration and fertility restoration. In this study, an exosome-laden scaffold (CS/Exos) was designed and the transplantation of CS/Exos potently induced (i) endometrium regeneration, (ii) collagen remodeling, (iii) increased the expression of the estrogen receptor α/progesterone receptor, and (iv) restored fertility. In mechanism, the construct of CS/Exos facilitated M2 macrophage polarization, reduced inflammation, and increased anti-inflammatory responses. Furthermore, miRNAs enriched in exosomes were the main mediator for exosome-induced macrophage polarization. This study highlights the therapeutic prospects of CS/Exos and the translational application for the management of severe IUAs.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Endometrium regeneration; Exosomes; Macrophages; Mesenchymal stem cells; miRNAs

Mesh:

Year:  2020        PMID: 32574858     DOI: 10.1016/j.actbio.2020.06.029

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  19 in total

Review 1.  Advances of exosomes in periodontitis treatment.

Authors:  Hongbing Lin; Huishan Chen; Xuetao Zhao; Tong Ding; Yawei Wang; Zhen Chen; Yue Tian; Peipei Zhang; Yuqin Shen
Journal:  J Transl Med       Date:  2022-06-21       Impact factor: 8.440

2.  Exosomes Derived From CTF1-Modified Bone Marrow Stem Cells Promote Endometrial Regeneration and Restore Fertility.

Authors:  Qianqian Zhu; Shengluan Tang; Yanwen Zhu; Di Chen; Jialyu Huang; Jiaying Lin
Journal:  Front Bioeng Biotechnol       Date:  2022-04-13

3.  Circ6401, a novel circular RNA, is implicated in repair of the damaged endometrium by Wharton's jelly-derived mesenchymal stem cells through regulation of the miR-29b-1-5p/RAP1B axis.

Authors:  Qin Shi; Baolan Sun; Di Wang; Yi Zhu; Xinxin Zhao; Xiaoqing Yang; Yuquan Zhang
Journal:  Stem Cell Res Ther       Date:  2020-12-01       Impact factor: 6.832

4.  The Top 100 Most Cited Articles on Intrauterine Adhesion: a Bibliometric Analysis.

Authors:  Pan Gu; Waixing Li; Xingping Zhao; Dabao Xu
Journal:  Reprod Sci       Date:  2021-11-15       Impact factor: 3.060

Review 5.  Focus on the Primary Prevention of Intrauterine Adhesions: Current Concept and Vision.

Authors:  Wen-Ling Lee; Chia-Hao Liu; Min Cheng; Wen-Hsun Chang; Wei-Min Liu; Peng-Hui Wang
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 5.923

6.  BMSC-derived extracellular vesicles intervened the pathogenic changes of scleroderma in mice through miRNAs.

Authors:  Jiahui Jin; Qingjian Ou; Zhe Wang; Haibin Tian; Jing-Ying Xu; Furong Gao; Shuqin Hu; Jie Chen; Juan Wang; Jieping Zhang; Lixia Lu; Caixia Jin; Guo-Tong Xu; Jingjun Zhao
Journal:  Stem Cell Res Ther       Date:  2021-06-05       Impact factor: 6.832

7.  Hierarchical cluster analysis in the study of the effect of cytokine expression patterns on endometrial repair and receptivity after hysteroscopic adhesiolysis.

Authors:  Bohan Li; Hua Duan; Sha Wang; Yiyi Wang; Yanan Chang; Zhengchen Guo; Yazhu Li
Journal:  Ann Transl Med       Date:  2021-05

Review 8.  Small extracellular vesicles from menstrual blood-derived mesenchymal stem cells (MenSCs) as a novel therapeutic impetus in regenerative medicine.

Authors:  Lijun Chen; Jingjing Qu; Quanhui Mei; Xin Chen; Yangxin Fang; Lu Chen; Yifei Li; Charlie Xiang
Journal:  Stem Cell Res Ther       Date:  2021-08-03       Impact factor: 6.832

Review 9.  The Complicated Effects of Extracellular Vesicles and Their Cargos on Embryo Implantation.

Authors:  Nan-Xing Jiang; Xue-Lian Li
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-04       Impact factor: 5.555

Review 10.  Therapeutic Role of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Female Reproductive Diseases.

Authors:  Zhiqi Liao; Chang Liu; Lan Wang; Cong Sui; Hanwang Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-23       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.